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Worldwide, cervical and uterine cancers are the most deadly cancers in women, with 
high prevalence, especially in developing countries. The Human Protein Atlas (HPA) 
portal was explored for proteins expressed in a tissue-or cervix and uterine cancer-
specific manner. The group of proteins differentially expressed, and with enhanced 
expression in the glandular and surface epithelial (squamous) cells retrieved from 
HPA were further explored using the Protein Information and Knowledge Extractor 
(PIKE) portal to compile biological information that is found in different databases, 
and repositories on the Internet. Thus, the lists of candidate proteins found in HPA, 
and PIKE portals may be used as a starting point for the discovery and validation 
of biomarkers for cervix and uterine cancer employing proteomics approaches as 
described in the present paper.
Acknowledgements M. A. Rodríguez-Pérez holds a scholarship from Comisión de Operación y Fomento 
de Actividades Académicas/Instituto Politécnico Nacional
(COFAA/IPN). M. A. Rodríguez-Pérez thanks COFAA/IPN for supporting travel expenses to attend the 
congress.
